Senate Health Panel To Hold User Fee Hearing With FDA Heads April 26

The Senate health committee on April 26 will hold its second user fee reauthorization hearing with testimony from the heads of FDA’s drug, biologics and device centers, Patrizia Cavazzoni, Peter Marks and Jeff Shuren, respectively, committee Chair Patty Murray (D-WA) announced Wednesday (April 20) . Murray said the hearing will focus on how to advance medical product regulation and innovations that benefit patients. During its first user fee hearing on April 5, members of the committee heard from the drug,...